Ir para o conteúdo
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avançada
  • Systemic review and economic e...
  • Citar
  • Enviar por SMS
  • Enviar por email
  • Imprimir
  • Exportar registo
    • Exportar para RefWorks
    • Exportar para EndNoteWeb
    • Exportar para EndNote
  • Permanent link
Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease

Systemic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease

Detalhes bibliográficos
Main Authors: Clark, W, Raftery, J, Song, F, Barton, P, Cummins, C, Fry-Smith, A, Burls, A
Formato: Journal article
Idioma:English
Publicado em: 2003
  • Exemplares
  • Descrição
  • Registos relacionados
  • Registo fonte

Registos relacionados

  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
    Por: Clark, W, et al.
    Publicado em: (2003)
  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease.
    Por: Clark, W, et al.
    Publicado em: (2003)
  • Systematic review and economic evaluation of the effectiveness of infliximab for the treatment of Crohn's disease
    Por: W. Clark, et al.
    Publicado em: (2003-01-01)
  • A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness
    Por: Chen, Y, et al.
    Publicado em: (2006)
  • A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness.
    Por: Chen, Y, et al.
    Publicado em: (2006)

Opções de Pesquisa

  • Histórico de Pesquisas
  • Pesquisa Avançada

Encontrar Mais

  • Percorrer o Catálogo
  • Percorrer por ordem alfabética
  • Explore Channels
  • Bibliografia Recomendada
  • Novos exemplares

Precisa de ajuda?

  • Dicas de Pesquisa
  • Serviço de Referência
  • FAQs